Risk of pneumonia with budesonide-containing treatments in COPD: an individual patient-level pooled analysis of interventional studies

Risk of pneumonia with budesonide-containing treatments in COPD: an individual patient-level pooled analysis of interventional studies

Sally Hollis,1 Carin Jorup,2 Dan Lythgoe,3 Gunnar Martensson,2 Pontus Regnell,2 Göran Eckerwall2 1AstraZeneca R&D, Alderley Park, Macclesfield, UK; 2AstraZeneca R&D, Gothenburg, Sweden; 3Phastar, Chiswick, London, UK Background: Concerns have been raised that treatment of...

Full description

Bibliographic Details
Main Authors: Hollis S, Jorup C, Lythgoe D, Martensson G, Regnell P, Eckerwall G
Format: Article
Language:English
Published: Dove Medical Press 2017-04-01
Series:International Journal of COPD
Subjects:
budesonide
COPD
inhaled corticosteroid
pneumonia
Online Access:https://www.dovepress.com/risk-of-pneumonia-with-budesonide-containing-treatments-in-copd-an-ind-peer-reviewed-article-COPD

Internet

https://www.dovepress.com/risk-of-pneumonia-with-budesonide-containing-treatments-in-copd-an-ind-peer-reviewed-article-COPD

Similar Items